Latest Capital Raise News

Centrex Limited has announced a $10.4 million entitlement offer to eligible shareholders, aiming to strengthen its financial position and support ongoing operations at the Ardmore phosphate mine. The offer is critical amid recent debt restructuring agreements with Aurizon and NAB.

Qoria Limited reports robust December quarter results for FY2025, driven by strong ARR growth, expanding global reach, and strategic AI innovations that promise to accelerate future growth.

Activeport has successfully closed a $6.1 million capital raise, including a significant placement to new institutional investor MWP Partners, positioning the company for accelerated growth in the global telecommunications and data centre software markets.

Centrex Limited has updated the timetable for its $10.4 million Entitlement Offer, with the offer opening on 28 January and closing on 19 February 2025. The company aims to bolster its position in sustainable agriculture through this capital raise.

Vonex Limited has terminated its proposed scheme with Maxo Telecommunications amid shareholder opposition, while MaxoTel’s 4.4c cash offer will close on January 28, 2025. The Vonex Board recommends shareholders accept MaxoTel’s offer and reject Swoop Telecommunications’ conditional scrip bid.

North Stawell Minerals has launched its 2025 diamond drilling program targeting significant gold mineralisation at the Wildwood and Darlington prospects in Victoria, backed by a recent $1.3 million capital raise.

Green Critical Minerals Limited (ASX: GCM) has temporarily paused trading of its securities, signaling an impending announcement that investors should watch closely.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Sipa Resources has inked agreements to acquire four advanced gold projects in South Australia and Western Australia, positioning itself for a significant exploration boost. The $2.2 million deal, coupled with a $1.75 million capital raise, signals a strategic pivot towards expanding its resource base.

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.

Megado Minerals has secured an agreement to acquire an 80% stake in a significant copper project in Spain and entered a strategic exploration deal for rare earths in the US, positioning itself at the forefront of critical minerals supply.

Nex Metals Explorations has repriced and partially completed its capital raise, securing $1.06 million at a reduced share price to fund development and exploration activities.